Multivariate Risk Group Stratified Analysis of the Predictive Value of Potentially Prognostic Factors of Leukemia-Related Events in 152 Children With Initial ALL
| Factor . | Relative Risk . | P Value Multivariate5-151 . |
|---|---|---|
| . | (95% C.I.)5-150 . | . |
| Age | ||
| <2 or ≥10 yr v 2-9 yr | 0.7 (0.3-1.5) | .33 |
| BFM risk factor5-152 | ||
| ≥1.20 v <1.20 | 1.8 (0.8-4.0) | .16 |
| Immunophenotype | ||
| Pro-B or T-cell v common or pre-B | 2.5 (0.9-7.0) | .09 |
| DNA ploidy | ||
| Nonhyperdiploid v hyperdiploid | 1.0 (0.2-4.8) | .97 |
| Drug-resistance profile | ||
| Resistant (score ≥7) v sensitive (score <7) | 7.0 (2.9-16.5) | <.001 |
| Factor . | Relative Risk . | P Value Multivariate5-151 . |
|---|---|---|
| . | (95% C.I.)5-150 . | . |
| Age | ||
| <2 or ≥10 yr v 2-9 yr | 0.7 (0.3-1.5) | .33 |
| BFM risk factor5-152 | ||
| ≥1.20 v <1.20 | 1.8 (0.8-4.0) | .16 |
| Immunophenotype | ||
| Pro-B or T-cell v common or pre-B | 2.5 (0.9-7.0) | .09 |
| DNA ploidy | ||
| Nonhyperdiploid v hyperdiploid | 1.0 (0.2-4.8) | .97 |
| Drug-resistance profile | ||
| Resistant (score ≥7) v sensitive (score <7) | 7.0 (2.9-16.5) | <.001 |